Literature DB >> 12574690

Viral infections in obstructive airway diseases.

Terence A R Seemungal1, Jadwiga A Wedzicha.   

Abstract

The most common syndromes associated with obstructive lung disease are asthma and chronic obstructive pulmonary disease (COPD). Evidence for a viral etiology of asthmatic exacerbations is well known, but evidence for a role for viruses in COPD exacerbation is just emerging. Viruses may cause chronic infection in both diseases. This paper reviews some studies on the effects of respiratory viruses on asthma and COPD published in 2002 and discusses their relevance to current thinking in pulmonary medicine.

Entities:  

Mesh:

Year:  2003        PMID: 12574690     DOI: 10.1097/00063198-200303000-00004

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  20 in total

1.  Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.

Authors:  Robert A Jenny; Claire Hirst; Sue Mei Lim; Adam L Goulburn; Suzanne J Micallef; Tanya Labonne; Anthony Kicic; Kak-Ming Ling; Stephen M Stick; Elizabeth S Ng; Alan Trounson; Antonietta Giudice; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

2.  Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

Authors:  Vasanthi Avadhanula; Carina A Rodriguez; John P Devincenzo; Yan Wang; Richard J Webby; Glen C Ulett; Elisabeth E Adderson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

Review 4.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 5.  [Antibiotic therapy for exacerbation].

Authors:  K Dalhoff; H Kothe
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

6.  Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Authors:  Ann R Falsey; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Wayne M Sullender; Edward E Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

7.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

8.  Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.

Authors:  Manisha Singh; Seung-Hyo Lee; Paul Porter; Chuang Xu; Ayako Ohno; Robert L Atmar; Stephen B Greenberg; Venkata Bandi; Jim Gern; Svetlana Amineva; Alex Aminev; Tim Skern; Pamela Smithwick; Sarah Perusich; Nadia Barrow; Luz Roberts; David B Corry; Farrah Kheradmand
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 9.  Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient.

Authors:  G Iyer Parameswaran; Timothy F Murphy
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model.

Authors:  P Wonganan; W C Zamboni; S Strychor; J D Dekker; M A Croyle
Journal:  Cancer Gene Ther       Date:  2008-12-26       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.